Strategic partnership COTA has a recent collaboration with Caris Life Sciences to expand multi-modal data offerings, indicating a receptive market for joint data initiatives and potential co-sell opportunities with providers expanding real-world data capabilities.

Platform expansion The launch of COTA’s real-world data platform in 2023 signals a growing demand for organized EHR-derived data to accelerate cancer research and AI model development, presenting upsell potential for enhanced data access tiers and analytics services.

AI and cloud leadership Recognition as a Google Cloud Customer of the Year and ongoing AI-enabled data abstraction use cases suggest opportunities to position COTA as a preferred cloud-and-AI data partner for healthcare organizations pursuing scalable oncology analytics.

Clinical data integration Strategic collaborations with Genomic Testing Cooperative and other data sources highlight a strong foothold in combining real-world outcomes with genomic profiling, enabling cross-sell of integrative data solutions to precision medicine teams.

Growth and leadership With a mid-market headcount and revenue in the tens of millions, COTA is positioned for expansion in life sciences and healthcare settings, offering potential to engage with mid- to large-sized hospitals and health systems seeking real-world evidence and analytics capabilities.